Malignant Endocrine Neoplasm — Trials

Malignant Endocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,801 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 576
Recruiting: 291
Ph III recruiting: 33
Growth YoY: +2.2%
Industry share: 34%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (238)

clinicaltrialsPublishedShowing 1–34 of 34 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06468696	Improvements in Thyroid Tumor Surgery and the Prognosis, Diagnosis, Recurrence and Metastasis of Patients	unknown	N/A	170	Second Affiliated Hospital of Xi'an Jiaotong UniversityOTHER	1	Jun 21, 2024	clinicaltrials
NCT06406660	Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer	unknown	N/A	20	Henan Cancer HospitalOTHER_GOV	1	May 9, 2024	clinicaltrials